Susquehanna International Group
APVO icon

Susquehanna International Group’s Aptevo Therapeutics APVO Stock Holding History

Susquehanna International Group’s Portfolio APVO Stock Details APVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Hold
0
– -$115K – 12816
2022
Q1 		– Hold
0
– – – 11801
2020
Q1 		– Hold
0
– -$10K – 10184
2019
Q4 		– Hold
0
– – – 9548
2019
Q3 		– Hold
0
– – – 9997
2019
Q2 		– Hold
0
– -$23K – 10171
2019
Q1 		– Hold
0
– – – 8577
2017
Q4 		– Hold
0
– -$94K – 9192
2017
Q3 		– Hold
0
– – – 8384
2017
Q2 		– Hold
0
– – – 8926
2017
Q1 		– Hold
0
– – – 8627
2016
Q4 		– Hold
0
– – – 9230

Other funds holding APVO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return